Day: April 26, 2024
BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 5,400 shares of its common stock under the Company’s 2023 Inducement Plan.
The stock options will vest over a four-year period, with 25% of each of the options vesting on the first anniversary of such employee’s start date, and 1/48th of the total shares vesting monthly thereafter, subject to continued employment on each vesting date.
About Tempest TherapeuticsTempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of...
Dynagas LNG Partners LP Announces Filing of Form 20-F With the SEC
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, April 26, 2024 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner and operator of liquefied natural gas (“LNG”) carriers, announced today that it has filed its Annual Report on Form 20-F for the year ended December 31, 2023 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”).
The Annual Report is available through the Partnership’s website.
Alternatively, unitholders may also receive a hard copy of the Annual Report, including the Partnership’s audited annual financial statements, free of charge, by request to Capital Link, Inc., using the contact details provided at the end of this press release.
About Dynagas LNG Partners LPDynagas LNG Partners LP. (NYSE: DLNG) is a master limited partnership which owns and operates liquefied natural gas (LNG) carriers...
Diamondback Energy, Inc. Receives Stockholder Approval for Proposed Transaction with Endeavor Energy Resources, L.P.
Written by Customer Service on . Posted in Mergers And Acquisitions.
MIDLAND, Texas, April 26, 2024 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced that its stockholders have approved the issuance of shares of Diamondback common stock in connection with the proposed business combination with Endeavor Energy Resources, L.P. (“Endeavor”).
Additionally, Diamondback stockholders approved a proposal to amend the Company’s certificate of incorporation to increase the authorized number of shares of Diamondback common stock.
The final voting results from Diamondback’s special meeting of stockholders will be set forth in a Form 8-K to be filed by Diamondback with the U.S. Securities and Exchange Commission.
The business combination with Endeavor is subject to customary closing conditions, including termination or expiration of the waiting period...
DDC Enterprise Limited Reports on NYSE American Noncompliance Notice
Written by Customer Service on . Posted in Public Companies.
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) — DDC ENTERPRISE LIMITED (NYSE AMERICAN: DDC) (“DAYDAYCOOK” OR THE “COMPANY”) announced today that on April 23, 2024, the Company received notice from NYSE American (the “Exchange”) that the Company currently is below the Exchange’s continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide, which requires the Company to have stockholders’ equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. The Exchange indicated that because the Company reported stockholders’ deficit of $(222,572,936) on June 30, 2023 and losses from continuing operations and/or net losses in its two most recent fiscal years ended December 31, 2022, the Company was not in compliance with Section...
Blackwell 3D Announces a $500,000 Public Offering Under Regulation A+
Written by Customer Service on . Posted in Public Companies.
DUBAI, UAE, April 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Blackwell 3D Construction Corp. (OTC: BDCC) (“Blackwell 3D” or the “Company”), The Company is pleased to announce the launch of a Regulation A+, Tier 1, equity financing of up to $500,000 dollars (the “Public Offering”). This Public Offering is a landmark event for the Company as it allows any individual 18 years or older to invest directly in the Company by purchasing freely tradable shares of our common stock. A copy of the Company’s offering circular for the Public Offering can be found on the Securities & Exchange Commission’s (“SEC”) website at https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=024-12412.
Blackwell 3D is an innovative 3D house printing technology company focused on revolutionizing the construction industry by printing...
Fentura Financial, Inc. Announces First Quarter 2024 Earnings (Unaudited)
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Dollars in thousands except per share amounts. Certain items in the prior period financial statements have been reclassified to conform with the March 31, 2024 presentation.
FENTON, Mich., April 26, 2024 (GLOBE NEWSWIRE) — Fentura Financial, Inc. (OTCQX: FETM) announces quarterly net income results of $2,790 for the three months ended March 31, 2024.
Ronald L. Justice, President and CEO, stated, “I am pleased with the progress we continue to make navigating a difficult operating environment as a result of challenges created by a multi-decades high increase in short-term interest rates over the last twenty-four months and a historically long and deep inversion of the yield curve. While this has impacted the level of profitability we experienced prior to this period, we ended the first quarter with record total assets and shareholders’...
Oxford Square Capital Corp. Schedules First Quarter 2024 Earnings Release and Conference Call for May 2, 2024
Written by Customer Service on . Posted in Public Companies.
GREENWICH, Conn., April 26, 2024 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a conference call to discuss first quarter 2024 earnings on Thursday, May 2, 2024 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-445-7795, verbal access code is OXFORD. There will be a recording available for 30 days after the call. If you are interested in hearing the recording, please dial 1-877-693-4280. The replay verbal passcode is OXFORD.
About Oxford Square Capital Corp.Oxford Square Capital Corp. is a publicly-traded business development company principally investing in syndicated bank loans and debt and equity tranches of collateralized loan obligation (“CLO”) vehicles. CLO investments may also include warehouse facilities, which are financing...
Bigbank’s Unaudited Financial Results for Q1 2024
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Bigbank’s total gross loan portfolio grew to a record 1.75 billion euros by the end of the first quarter, increasing by 86 million euros (+5%) over the quarter and by 325 million euros (+23%) year-on-year. During the quarter, the corporate loan portfolio grew by 22 million euros (+4%) to 600 million euros, the housing loan portfolio by 43 million euros (+12%) to 394 million euros and the consumer loan portfolio by 25 million euros (+3%) to 762 million euros.
The savings deposit portfolio and the term deposit portfolio grew at fairly equal rates in the first quarter. The Group’s total deposit portfolio increased by 215 million euros (+11%) over the quarter and by 655 million euros (+44%) year-on-year, expanding to 2.15 billion euros. The term deposit portfolio increased by 100 million euros (+11%) to 1.02 billion euros, exceeding the 1-billion-euro...
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Written by Customer Service on . Posted in Public Companies.
BEIJING, China, April 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in biological research reagents and related technical contract research services, has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. (“SCB” or “SignalChem”). Sino Biological has acquired 100% of SCB shares in a deal valued at $48M USD, inclusive of all assets, assumed indebtedness, and net of cash deposits.
SignalChem Biotech Inc. is renowned for its specialized bioactive enzymes, including kinases, proteases, phosphatases, ubiquitin and epigenetic enzymes. Over the past two decades, SCB has established...
SYNERGIE : SYNERGIE announces the release of its 2023 Annual Financial Report
Written by Customer Service on . Posted in Public Companies.
SYNERGIE announces the release of its2023 Annual Financial Report
Paris, 26 April 2024: SYNERGIE announces that its 2023 Annual Financial Report (french version) is available on its website www.synergie.com
About SYNERGIE
A European specialist in Human Resources Management, SYNERGIE covers all employment-related needs. With a network of 800 branches in Europe, Canada and Australia, the Group generated a 2023 consolidated revenue of €3,108.5 million, which international business accounted for 58%. The strategy employed by SYNERGIE Group is based on an active organic and external growth policy that is intended to strengthen its positioning as a key European actor.
Euronext Paris Compartiment B ISIN FR0000032658, mnémo SDGReuters SDGI.PA, Bloomberg SDG:FPwww.synergie.com
160 bis rue de Paris – 92100 Boulogne BillancourtSE (European...